The Canadian tech giant manages its global business out of Ireland and new accounts detail a boost in revenue and profits and a continuing reduction in headcount.
How should a pharma multinational respond to the uncertainty unleashed by the Trump administration? Invest more in Ireland, the contact-lens and eye-drop giant appears to have decided.
With a mutual interest in circumventing US tariffs, Ireland and Canada are getting closer, an Irish trade mission to Toronto found – but a Trump-triggered recession could yet scupper efforts to boost business between the two.
Ireland has yet to ratify the EU-Canada trade deal, due to a Supreme Court legal challenge, but Simon Harris is marching on with a bill to sign off on the agreement.
The Canadian company successfully pushed back on two broad data requests by Canada’s tax agency. The application of GDPR to the data held by its Irish base factored into the argument.
Amid the backdrop of Trump’s tariff agenda, the Irish government has committed to finally ratifying the Ceta free trade deal. But legal questions linger over its built-in investor court.
A High Court judge has refused Paddy Digan’s application for summary judgment against the founder of now-defunct Pharmapod over a contentious loan. The dispute sheds light on the circumstances surrounding the company's demise.
The AI legal research start-up launched in recent weeks after incorporating in Ireland. Now it’s been hit with a lawsuit in Canada by a non-profit, alleging it wrongfully accessed its data.
The Canadian tech firm booked a profit through its international HQ in Ireland, which manages the Emea and South American markets and uses a green jersey tax structure.
Pharmapod’s assets were sold last year through a pre-pack receivership for around €1.5m. Now, creditors of the Irish software company are poised to wind up the remnants of the company.
© 2026 Currency Media Limited
